FdaApplication

NDA 050605

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGLAXOSMITHKLINE
application_typeNDA
approval_date1987-12-28

Products (3)

ProductActive ingredientStrengthDosage form
CEFTINCEFUROXIME AXETILEQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL
CEFTINCEFUROXIME AXETILEQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL
CEFTINCEFUROXIME AXETILEQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL

3 products